The glucagon component is one reason researchers are interested in how retatrutide may affect energy expenditure, fat metabolism, liver fat, and overall weight-loss response
For forward-thinking formulators and brands, this creates a dual opportunity: address GI discomfort and support muscle retention with targeted, science-backed ingredients
Seniors can get their first look at new 2026 plans starting on Wednesday, ahead of the actual start of open enrollment Oct
If the FDA approves GLP-1 weight loss patches in the future, patients using the patches may experience similar side effects as subcutaneous GLP-1 injections, including GI-related adverse effects
21 Aiming for the general recommendations (around 25 grams/day for women, 38 grams/day for men) is a good starting point, adjusting based on individual tolerance
In February, researchers from the University of Leicester and the Leicester Diabetes Centre published a review article on obesity in the "International Journal of Obesity," introducing the current and future drug development pipeline for the treatment of obesity, with special attention given to novel therapies based on the mechanisms of gut incretin hormones